Clinical trials: Bilateral Stent Insertion
Hilar Cholangiocarcinoma
Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma
Cholangiocarcinoma (CCA) is the most common biliary malignancy and the second most common hepatic malignancy after hepatocellular carcinoma (HCC).
- Trial name
- NCT02108145
- Testing
- bilateral metal stent insertion, unilateral metal stent insertion
- Where
- China
- Volunteers
- 70 people
- Sponsor
- Air Force Military Medical University, China
Malignant Hilar Stricture, Bilateral Stent Insertion
Two Bilateral Metal Stenting in Hilar Malignancy
The overall median survival of nonresectable malignant hilar obstruction in most series has been less than 6 months. Most patients with malignant hilar obstruction present with advanced disease, making allative endoscopic…
- Trial name
- NCT01141088
- Testing
- Bilateral stent-in-stent insertion, Bilateral side-by-side insertion
- Where
- 2 sites in South Korea
- Volunteers
- 80 people
- Sponsor
- Soon Chun Hyang University